<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03904303</url>
  </required_header>
  <id_info>
    <org_study_id>REG-014-2018</org_study_id>
    <nct_id>NCT03904303</nct_id>
  </id_info>
  <brief_title>Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep</brief_title>
  <official_title>Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep. A Randomized Single-blinded Cross-over Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Crossover study comparing Moviprep (for bowel cleansing) with a new gel-based colon cleansing
      agent before colonoscopy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Crossover study comparing Moviprep (for bowel cleansing) with a new gel-based colon cleansing
      agent before colonoscopy.

      Study performed in health subjects.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Boston Bowel preparation scale (BBPscale)</measure>
    <time_frame>Performed during the endoscopy procedure</time_frame>
    <description>Visual assessment of the degree of bowel cleansing performed by the endoscopist (blinded). Right colon, colon transversum, and left colon are each judged on a scale from 0-3 with higher scores indicating better cleansing. Range of score between 0-9.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events related to intervention</measure>
    <time_frame>Assessed 4 hours after last intake of cleansing product</time_frame>
    <description>Any adverse event related to the intervention observed by investigators or as reported by the participant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Measured immediately before the colonoscopy starts, and every 5 minutes during colonoscopy and immediately after the end of the examination</time_frame>
    <description>mmHg systolic and diastolic measured on right or left arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saturation</measure>
    <time_frame>Measured immediately before the colonoscopy starts, and every 5 minutes during colonoscopy and immediately after the end of the examination</time_frame>
    <description>Oxymeter measuring the saturation of hemoglobin with oxygen as a percentage of 0-100%.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Measured immediately before the colonoscopy starts, and every 5 minutes during colonoscopy and immediately after the end of the examination</time_frame>
    <description>Heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiration frequency</measure>
    <time_frame>Measured immediately before the colonoscopy starts, and every 5 minutes during colonoscopy and immediately after the end of the examination</time_frame>
    <description>Respiration frequency</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Pharmacological Action</condition>
  <arm_group>
    <arm_group_label>Geloprep</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Novel and patented Polyethylene glycol 3350 mixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moviprep</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard of care Polyethylene glycol 3350 mixture</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>A 06 ad</intervention_name>
    <description>Colonic cleansing before colonoscopy and CT colonografi</description>
    <arm_group_label>Geloprep</arm_group_label>
    <arm_group_label>Moviprep</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Healthy

        Exclusion Criteria:

          -  Allergy to content of products
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ismail Gögenur, Professor MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Surgery, Zealand University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanne Holm, RN</last_name>
    <phone>+4593567014</phone>
    <email>hanh@regionsjaelland.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Svend Knuhtsen, MD</last_name>
    <phone>+4523348555</phone>
    <email>svkn@regionsjaelland.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zuh</name>
      <address>
        <city>Køge</city>
        <state>Region Of Zealand</state>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>January 29, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2019</study_first_posted>
  <last_update_submitted>June 3, 2019</last_update_submitted>
  <last_update_submitted_qc>June 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

